Please be aware that this is a machine translation from French to English. AVICENN is not responsible for incorrect or inaccurate translations but welcomes suggestions for reformulation.

VeilleNanos - Nanomedicine: promises and risks

Nanomedicine: promises and risks

image
cards
News
Agenda

Nanomedicine, transhumanism and NBIC in the medical field: promises and risks

By AVICENN – Last updated March 2025

The acronym NBIC refers to the convergence of nanotechnologies (N) with biotechnologies (B), information sciences (I), and cognitive sciences (C).

Some quotes as a preamble:

“In the utopian hope of being able to conquer death and suffering through the limitless power of our science, all of us, doctors, patients, health authorities, politicians… get drunk on the uninterrupted flow of discoveries that biotechs like to announce with great fanfare. Drunkenness sometimes leads to absurdity (…). This leads to a real problem ofhealth equity: all other things being equal, patients who can benefit from sophisticated treatments will receive more resources from the national solidarity than those requiring “human” care, considered less prestigious. – Bruno Falissard, “ Medicine is the best alibi for technoscientific hubris “, Le Monde, September 2022.

“In the 1960s, during the presidency of Richard Nixon, the U.S. administration had decreed a “war on cancer.” The promise was that “in 10 years, we will have won”. Lots and lots of money was spent. Not everything has been in vain, but this war has obviously not been won”. – Jean-Marc Lévy-Leblond, “There is no democratic control of science,” Critical Science, December 2015.

“New curative advances still allow those without excellent intrinsic longevity to nibble away a few years of life after age 65. However, these results are nothing compared to the preventive measures known as hygienic-dietary rules. These can be summarized as three: regular walking, caloric restriction and smoking cessation. Their results are far superior to any pharmacological or instrumental interventions in most neurodegenerative, tumor, cardiovascular, infectious and locomotor pathologies“. – Luc Perino, excerpt from “Refusing death can be deadly,” in For Health Reasons – Medicine and the Facts, July 8, 2015.

Promises of nanomedicine and NBICs in the medical field

General or synthetic documents on nanomedicine

In French :

In English:

More "specialized" or focused documents

In French :

→ English:

Risks, regulation and societal issues raised by nanomedicine, transhumanism and NBIC in the medical field

Explore the bibliography

English:

Any questions or comments? This information sheet compiled by AVICENN is intended to be completed and updated. Please feel free to contribute.

Upcoming Nano Agenda

3
Avr.
2025
Dimensional analysis by electron and atomic force microscopy of particles (NanoMesureFrance, Online)
On line
Webinar
  • Webinar presenting the example guide produced by NanoMesureFrance, to illustrate the difficulties encountered in dimensional analysis of particles by electron and atomic force microscopy.
  • Organizers: Association NanoMesureFrance
  • Speakers: Valérie Godefert & François-Xavier Ouf (LNE & NanoMesureFrance)
  • Website: www.eventbrite.fr/…nanomesurefrance-webinar-…

14
Avr.
2025
Advanced Characterization Techniques in Nanomaterials and Nanotechnology (Nano2025, Rome – Italy)
Rome
Congress
  • Advanced Characterization Techniques in Nanomaterials and Nanotechnology 
  • 10th European Congress on Advanced Nanotechnology and Nanomaterials
  • 14 and 15 April 2025
  • Website: https://nanomaterialsconference.com
13
Mai
2025
5th Joint Symposium on Nanotechnology (BfR & Fraunhofer Nanotechnology Network – Würzburg, Germany)
Würzburg
Conference
  • 5th Joint Symposium on Nanotechnology
  • Organizers: the Fraunhofer Nanotechnology Network, with the support of the Federal Institute for Risk Assessment (BfR)
  • Date: May 13-14, 2025
  • Topics:
    • the application of nanotechnology in various sectors, including digitalization, 2D/3D printing, carbon-based materials and battery materials
    • nano on various regulations (REACh, food contact materials, cosmetics, bioagents, PPPs)
    • adaptation and development of OECD Test Guidelines for nano and advanced materials (Malta Initiative)
    • review on nano-specific NAMs (new approach methodologies)
    • when you’re nano and you know it: dealing with uncertainty regarding the nanomaterial definition in regulatory frameworks
  • Website: www.isc.fraunhofer.de/…2025/5th-symposium-nanotechnology.html

This sheet was originally created in February 2019


Our monitoring, information and actions need you to continue !